Skip to main content

Peer Review reports

From: Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational status

Original Submission
23 Dec 2014 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
12 Mar 2015 Editorially accepted
26 Mar 2015 Article published 10.1186/s12885-015-1186-0

You can find further information about peer review here.

Back to article page